Characteristic | Training dataset (n = 143) |  | Test dataset (n = 61) | p value | |||||
---|---|---|---|---|---|---|---|---|---|
GBM (n = 102) | SBM (n = 41) | p value |  | GBM (n = 44) | SBM (n = 17) | p value |  | ||
Age, years | Â | Â | Â | Â | Â | Â | Â | Â | |
 Mean ± SD | 52.1 ± 12.0 | 56.5 ± 11.6 | 0.516 |  | 53.0 ± 9.7 | 55.4 ± 11.4 | 0.451 | 0.347 | |
Sex, n | Â | Â | 0.855 | Â | Â | Â | 0.763 | 0.832 | |
 Male (%) | 58 (56.8) | 24 (58.5) |  |  | 24 (54.5) | 10 (58.8) |  |  | |
 Female (%) | 44 (43.2) | 17 (41.5) |  |  | 20 (45.5) | 7 (41.2) |  |  | |
Variety of SBM, n | Â | Â | Â | Â | Â | Â | Â | Â | |
 Lung, n |  |  |  |  |  |  |  |  | |
  Adenocarcinoma (%) |  | 28 (68.3) |  |  |  | 13 (76.4) |  |  | |
  Squamous cell carcinoma (%) |  | 2 (4.9) |  |  |  |  |  |  | |
  Neuroendocrine carcinoma (%) |  | 3 (7.4) |  |  |  | 1 (5.9) |  |  | |
  Small cell lung carcinoma (%) |  | 1 (2.4) |  |  |  |  |  |  | |
  Poorly differentiated carcinoma (%) |  | 1 (2.4) |  |  |  |  |  |  | |
 Stomach, n |  |  |  |  |  |  |  |  | |
  Adenocarcinoma (%) |  | 1 (2.4) |  |  |  | 0 |  |  | |
 Kidney, n |  |  |  |  |  |  |  |  | |
  Clear cell carcinoma (%) |  | 3 (7.4) |  |  |  | 1 (5.9) |  |  | |
 Uterus, n |  |  |  |  |  |  |  |  | |
  Endometrial carcinoma (%) |  | 1 (2.4) |  |  |  | 1 (5.9) |  |  | |
 Unknown site, n (%) |  | 1 (2.4) |  |  |  | 1 (5.9) |  |  |